EUVIMEDEUVIMED entdecken
Crossref

Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors

Yaojia Li, Jiahui Zhou, Xiaoxing Wu, Wei Li, Zhe Wang, Jianchen Yang, Genzoh Tanabe, Osamu Muraoka, Weijia Xie iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Yaojia Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, P. R. China. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, alpha-Glucosidases, Drug Design, Sulfonium Compounds. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of sulfonium, selenonium, and ammonium salts featuring diverse benzylidene acetal side chain substituents are designed and synthesized. In contrast to the previous work, this study emphasized stereochemical inversion at the 3′‐position and bioisosteric replacements at the sulfonium cationic center. In vitro α ‐glucosidase inhibition assays identified 20b , 20l , and 21b as potent inhibitors. In vivo, 20b (15.0 mg kg −1 ) reduced postprandial blood glucose levels in sucrose‐loaded mice by 40.6% (15 min), 49.5% (30 min), and 43.6% (60 min), surpassing acarbose (20.0 mg kg − 1 ). Molecular docking of 20b with the N‐terminal subunit of Maltase‐Glucoamylase ( nt MGAM) revealed an identical binding mode, where 3′‐stereoinversion induced π– π stacking between the benzylidene acetal phenyl ring and Phe450 and electrostatic interactions between the ortho‐nitro group and Asp203. Cytotoxicity assessments confirmed the favorable safety profile of selected compounds in normal cell lines. Enzyme kinetic studies demonstrated fully competitive inhibition of α ‐glucosidase by these sulfonium salts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycoside Hydrolase Inhibitorsalpha-GlucosidasesDrug DesignSulfonium CompoundsOrganoselenium CompoundsBenzylidene CompoundsAnimalsMiceStructure-Activity RelationshipMolecular Docking SimulationHumansMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

Salaciaα‐glucosidase inhibitorselenonium saltsstereo‐inversionsulfonium salts

Substanzen

Glycoside Hydrolase Inhibitorsalpha-GlucosidasesSulfonium CompoundsOrganoselenium CompoundsBenzylidene Compounds

Autor:innen und Institutionen

  • School of Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, P. R. China.
  • School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, P. R. China.
  • Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, 78712, USA.
  • School of Pharmacy, Kinki University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.

ORCID-Profile: Weijia Xie

Förderung

  • National Key R&D Program of China

Zitieren

APA

Li, Y., Zhou, J., Wu, X., Li, W., Wang, Z., Yang, J., Tanabe, G., Muraoka, O., & Xie, W. (2025). Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.202500299

Vancouver

Li Y, Zhou J, Wu X, Li W, Wang Z, Yang J, et al. Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors. ChemMedChem. 2025. doi:10.1002/cmdc.202500299

BibTeX
@article{Li2025,
  author = {Li, Yaojia and Zhou, Jiahui and Wu, Xiaoxing and Li, Wei and Wang, Zhe and Yang, Jianchen and Tanabe, Genzoh and Muraoka, Osamu and Xie, Weijia},
  title = {Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500299}
}
Kostenlos starten →